Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
approved publishing date : 2021 - 06 - 10 save search
Fly Leasing Shareholders Approve Acquisition by Carlyle Aviation
Published: 2021-06-10 (Crawled : 21:00) - prnewswire.com
CG | $46.13 -0.43% -0.43% 1.4M
|
Finance
|
| O: 0.55%
H: 0.14%
C: -0.16%
acquisition approval
WSFS and BMTC Receive Stockholder Approval to Combine
Published: 2021-06-10 (Crawled : 21:00) - bmt.com
WSFS 4 | $45.03 0.16% 0.16% 230K
|
Finance
|
| O: 0.65%
H: 0.55%
C: -0.4%
approval
Photo Release -- WSFS and BMTC Receive Stockholder Approval to Combine
Published: 2021-06-10 (Crawled : 21:00) - globenewswire.com
WSFS 4 | $45.03 0.16% 0.16% 230K
|
Finance
|
| O: 0.65%
H: 0.55%
C: -0.4%
approval
Leaf Group Announces Shareholder Approval of Merger Agreement with Graham Holdings
Published: 2021-06-10 (Crawled : 17:00) - globenewswire.com
GHC | $717.44 -0.2% 0.0% 17K
|
Consumer Services
|
| O: 0.0%
H: 0.07%
C: -0.93%
merger agreement merge approval
Medtronic Announces FDA Approval of its Next Generation Recharge-Free Spinal Cord Stimulation Platform
Published: 2021-06-10 (Crawled : 14:00) - biospace.com/
MDT | $80.38 -1.12% 0.0% 5M
|
Health Technology
|
| O: 0.73%
H: 0.74%
C: 0.59%
fda fda approval spinal cord approval
GeneTx and Ultragenyx Receive Approval from U.K. Regulatory Agency to Begin Clinical Study of GTX-102 for the Treatment of Angelman Syndrome
Published: 2021-06-10 (Crawled : 13:00) - globenewswire.com
RARE F | $44.26 -1.88% -1.92% 670K
|
Health Technology
|
| O: 0.2%
H: 8.89%
C: 5.07%
treatment approval syndros
Former STB Commissioner and Vice-Chairman, William Clyburn, Jr., Believes CN Voting Trust Should be Approved
Published: 2021-06-10 (Crawled : 12:15) - globenewswire.com
CNI | $122.86 -5.05% -0.01% 2.4M
|
Transportation
|
| O: 0.44%
H: 0.65%
C: -0.19%
approval
Cardinal Health™ Nuclear & Precision Health Solutions Receives U.S. Food and Drug Administration Approval for New LYMPHOSEEK® Pediatric Indication
Published: 2021-06-10 (Crawled : 12:00) - biospace.com/
CAH | $103.54 0.16% -0.52% 2.1M
|
Distribution Services
|
| O: 0.5%
H: 2.23%
C: 1.97%
food drug approval health
FDA grants accelerated approval to amivantamab-vmjw for metastatic non-small cell lung cancer
Published: 2021-06-10 (Crawled : 10:52) - fda.gov
GH | News 4 | $18.1 4.38% 4.2% 1.6M
|
Health Services
|
| O: -0.54%
H: 7.61%
C: 6.07%
cancer fda granted approval grant
FDA approves nivolumab in combination with chemotherapy for metastatic gastric cancer and esophageal adenocarcinoma
Published: 2021-06-10 (Crawled : 10:43) - fda.gov
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: 0.23%
H: 3.28%
C: 2.81%
cancer fda fda approval nivolumab
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.